US 6656474
Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
expired A61KA61K2039/505A61K38/185
Quick answer
US patent 6656474 (Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/505, A61K38/185, A61P, A61P1/00